These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6681855)

  • 1. [Technic of isolated perfusion of the extremities. Experience with 171 cases].
    Aigner K; Schwemmle K
    Langenbecks Arch Chir; 1983; 359(2):113-22. PubMed ID: 6681855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New modifications in isolated extremity perfusion ].
    Aigner K; Hild P; Hundeiker M
    Z Hautkr; 1982 Jul; 57(14):1044-54. PubMed ID: 6889794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hyperthermic isolation perfusion of the extremities in malignant melanomas and soft tissue sarcomas].
    Tonak J; Hohenberger W; Göhl J
    Chirurg; 1984 Aug; 55(8):499-504. PubMed ID: 6488994
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of hyperthermic perfusion in the treatment of tumors of the extremities.
    Di Filippo F; Carlini S; Cavaliere F; Giannarelli D; Cavallero L; Moscarelli F; Aloe L; Cavaliere R
    Adv Exp Med Biol; 1990; 267():223-34. PubMed ID: 2088040
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tumor necrosis factor α and melfalan-based hyperthermic isolated limb perfusion in locally advanced extremity soft tissue sarcomas and melanomas].
    Alegre JF; Duarte M; Sureda González M; Bretcha Boix P; Dussan C; Ballester A; Crespo A; Brugarolas Masllorens A
    Cir Esp; 2012 Feb; 90(2):114-20. PubMed ID: 22225611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of melphalan leakage during hyperthermic isolation perfusion in melanoma of the limb.
    Rauschecker HF; Foth H; Michaelis HC; Horst F; Gatzemeier W; Willenbrock C; Voth E; Kahl GF
    Cancer Chemother Pharmacol; 1991; 27(5):379-84. PubMed ID: 1998997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperthermic isolated limb perfusion for recurrent melanomas and soft tissue sarcomas: feasibility and reproducibility in a multi-institutional Hellenic collaborative study.
    Lasithiotakis K; Economou G; Gogas H; Ioannou C; Perisynakis K; Filis D; Kastana O; Bafaloukos D; Decatris M; Catodritis N; Frangia K; Papadakis G; Magarakis M; Tsoutsos D; Chrysos E; Chalkiadakis G; Zoras O
    Oncol Rep; 2010 Apr; 23(4):1077-83. PubMed ID: 20204294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of isolation-perfusion of the limbs in melanomas and sarcomas].
    Lejeune F; Liénard D; Eggermont A; Schraffordt Koops H; Kroon B
    Ann Chir; 1995; 49(1):9-12. PubMed ID: 7741477
    [No Abstract]   [Full Text] [Related]  

  • 9. Patient- and treatment-related factors associated with acute regional toxicity after isolated perfusion for melanoma of the extremities.
    Klaase JM; Kroon BB; van Geel BN; Eggermont AM; Franklin HR; Hart GA
    Am J Surg; 1994 Jun; 167(6):618-20. PubMed ID: 8209941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seven years experience with hyperthermic perfusions in extracorporeal circulation for melanoma of the extremities.
    Santinami M; Belli F; Cascinelli N; Rovini D; Vaglini M
    J Surg Oncol; 1989 Nov; 42(3):201-8. PubMed ID: 2811386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Isolated hyperthermic extremity perfusion with vindesine, dacarbazine and cisplatin in the treatment of malignant melanomas].
    Aigner KR; Jungbluth A; Link KH; Walther H; Müller H; Schwemmle K; Ringenberg T; Börger G; Ruppel R; Illig L
    Onkologie; 1984 Dec; 7(6):348-53. PubMed ID: 6396562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiocirculatory side effects of hyperthermic extremity perfusion].
    Omlor G; Molter G; Meessen S; Gross G; Seyfert U; Feifel G
    Langenbecks Arch Chir; 1993; 378(1):17-20. PubMed ID: 8437497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy of melanoma of the extremities by perfusion: fourteen years clinical experience.
    Krementz ET; Ryan RF
    Ann Surg; 1972 Jun; 175(6):900-17. PubMed ID: 4625027
    [No Abstract]   [Full Text] [Related]  

  • 14. [Soft tissue sarcoma: isolated hyperthermic extremity perfusion. Technique and indications].
    Schlag PM; Kettelhack C
    Chirurg; 1993 Jun; 64(6):455-60. PubMed ID: 8359057
    [No Abstract]   [Full Text] [Related]  

  • 15. Hyperthermic isolation limb perfusion (HILP) in the management of extremity melanoma and sarcoma with particular reference to the dosage, pharmacokinetics, and toxicity of cisplatin.
    Fletcher WS; Woltering EA; Moseley HS; Bos G; Lebredo L; Brown D; Small K
    Cancer Treat Res; 1993; 62():241-4. PubMed ID: 8096739
    [No Abstract]   [Full Text] [Related]  

  • 16. [Isolated limb hyperthermic perfusion chemotherapy for melanoma of the extremities].
    Li J; Wang P; Zhu XJ; Song JG; Song JM
    Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):937-9. PubMed ID: 23336382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Improved intraoperative leak control in cytostatic drug isolation perfusion of tumors of the extremities].
    Manner M; Sinn H; Bubeck H; Kettelhack C; Schlag P
    Langenbecks Arch Chir; 1990; 375(4):208-13. PubMed ID: 2395387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional isolated perfusion of extremities for melanoma: now a 26-year experience with drugs other than L-phenylalanine mustard.
    Ariyan S
    Plast Reconstr Surg; 2003 Mar; 111(3):1257-61. PubMed ID: 12621200
    [No Abstract]   [Full Text] [Related]  

  • 19. Regional perfusion with cis-platinum and dacarbazine.
    Aigner K; Hild P; Henneking K; Paul E; Hundeiker M
    Recent Results Cancer Res; 1983; 86():239-45. PubMed ID: 6685902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Technique and results of hyperthermic perfusion of the extremity in melanoma patients].
    Omlor G; Bahmer F; Meessen S; Zang D; Feifel G; Zaun H
    Langenbecks Arch Chir; 1993; 378(1):21-5. PubMed ID: 8437498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.